Welcome to our dedicated page for Transcat SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Transcat Inc (Nasdaq: TRNS), a provider of accredited calibration services, cost control and optimization services, and distribution and rental of professional grade handheld test, measurement, and control instrumentation. These regulatory documents offer detailed insight into Transcat’s operations, governance, and financial condition.
Through its periodic reports such as the Form 10-K and Form 10-Q (not reproduced here), Transcat describes its two operating segments—Service and Distribution—its focus on highly regulated industries including Life Science, aerospace and defense, energy and utilities, and industrial manufacturing, and the risks and opportunities associated with its calibration and distribution activities.
Current reports on Form 8-K are particularly relevant for tracking material events. Recent 8-K filings have disclosed the completion of the Essco Calibration Laboratory acquisition, entry into a new five-year $150 million secured revolving credit facility, quarterly earnings releases, executive leadership changes, and a CEO transition agreement. Other 8-Ks detail equity retention awards for certain executive officers and the appointment or retirement of key finance and board personnel.
Transcat’s proxy statement on Form DEF 14A outlines its board structure, committee composition, Corporate Governance Guidelines, executive compensation programs, and matters submitted to shareholder votes, such as director elections, say-on-pay, and auditor ratification. The proxy materials also summarize the company’s description of its business and strategic priorities, including its acquisition strategy.
On Stock Titan, investors can use AI-powered tools to quickly interpret these filings, with summaries that highlight items such as segment definitions, acquisition terms, credit facility covenants, and compensation arrangements. Filings related to executive equity awards, succession planning, and shareholder meeting results are especially useful for understanding how Transcat’s governance and capital allocation decisions may relate to TRNS stock.
Transcat, Inc. disclosed that its Compensation Committee approved a special one-time equity retention package for four executive officers under the 2021 Stock Incentive Plan. The awards are in the form of restricted stock units, with grants of 19,772 RSUs to Thomas L. Barbato, 10,380 to Theresa A. Conroy, 5,190 to Michael J. Haddad, and 12,028 to Michael W. West.
The retention awards are scheduled to vest on January 6, 2028, conditioned on each executive’s continued employment and as otherwise detailed in the award agreements. The company explains that these awards are intended to preserve leadership continuity during the transition to a successor chief executive officer and to directly incentivize the executives’ ongoing contributions.
Transcat, Inc. reported Q2 FY2026 results with total revenue of $82.3 million, up 21.3% year over year. Service revenue was $52.8 million and Distribution revenue was $29.4 million. Gross profit rose to $26.8 million with a total gross margin of 32.5%.
Operating income was $3.5 million as operating expenses increased with acquisitions and higher compensation. Net income was $1.3 million and diluted EPS was $0.14. Interest and other expense increased to $1.5 million, reflecting higher borrowings.
For the first six months, revenue reached $158.7 million and net income was $4.5 million. Operating cash flow was $16.5 million, while investing cash flow used $91.6 million, primarily for acquisitions. The company closed a new five‑year $150.0 million secured revolving credit facility; $111.9 million was outstanding as of September 27, 2025. Transcat acquired Essco for approximately $85.6 million and earlier acquired Martin for approximately $81.8 million. Total assets were $484.9 million, long‑term debt was $111.9 million, and shares outstanding were 9,328,412 as of October 31, 2025.
Transcat, Inc. (TRNS) announced fiscal 2026 second‑quarter results for the period ended September 27, 2025, via a press release furnished as Exhibit 99.1. The company also posted investor presentation slides (Exhibit 99.2) on its website to accompany an earnings conference call and webcast scheduled for 4:30 p.m. Eastern Time on November 3, 2025.
The materials are furnished under Item 2.02 and are not deemed filed under the Securities Exchange Act of 1934.
Robert Mecca, a director of Transcat Inc. (TRNS), reported equity award activity on 09/10/2025 and 09/11/2025. On 09/10/2025 the filing shows restricted stock units (RSUs) granted totaling 1,587 RSUs that convert one-for-one into common stock and, per the award terms, generally vest on September 10, 2026. On 09/11/2025 a separate tranche of 704 RSUs is reported as vested, converting into common stock. The filing also discloses a stock option covering 10,000 shares with an exercise price of $98.88 and an expiration date of January 24, 2034; this option vests pro rata over five years. The form is signed by an attorney-in-fact on behalf of Mr. Mecca on September 11, 2025. The disclosure is limited to these award and vesting events and does not include earnings, cash transactions, or other operational details.
Transcat Inc. (TRNS) director Mbago M. Kaniki received equity awards and holds an option position. The filing reports conversion-eligible restricted stock units (RSUs) that convert one-for-one into common stock. RSUs granted 09/10/2025 total 1,587 shares and vest on 09/10/2026. An additional 704 RSUs vested and converted on 09/11/2025, increasing beneficial ownership by 704 shares. The reporting person also holds a stock option to buy 10,000 shares at $47.14 per share exercisable on a pro rata vesting schedule through 05/12/2031. After the reported transactions, the filer directly beneficially owns 2,593 shares.
Gary J. Haseley, a director of Transcat Inc. (TRNS), reported equity changes arising from restricted stock unit (RSU) activity in September 2025. On September 11, 2025 704 shares were acquired following RSU vesting at no cash cost. Following that transaction, Mr. Haseley held 39,102 shares directly. The filing also shows 1,200 shares held indirectly through family trusts.
Separately, on September 10, 2025 he received an award of 1,587 RSUs granted under a Rule 16b-3 exempt transaction; those RSUs vest on September 10, 2026 and convert one-for-one to common stock when vested. The filing is a routine Section 16 disclosure documenting vesting and a new RSU grant.
Christopher P. Gillette, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership on Form 4. The filing shows 704 shares were acquired on 09/11/2025 through the vesting of restricted stock units (RSUs) and are reported with a $0 per-share conversion value. The document also discloses an earlier RSU grant of 1,587 RSUs dated 09/10/2025 that convert one-for-one to common stock and generally vest on 09/10/2026. In addition, Mr. Gillette holds a stock option covering 10,000 shares with an exercise price of $109.55 and pro rata vesting over five years. The filing was signed by an attorney-in-fact on behalf of Mr. Gillette on 09/11/2025.
Reporting person: Dawn DePerrior, a director of Transcat, Inc. (TRNS). The Form 4 discloses equity awards and option activity reported for transactions on September 10-11, 2025. On 09/10/2025 Ms. DePerrior was awarded 1,587 restricted stock units (RSUs) that convert one-for-one into common shares and vest on 09/10/2026. On 09/11/2025 704 RSUs vested and converted into 704 shares of common stock, increasing her beneficial ownership by that amount. Also reported is a stock option to purchase 10,000 shares at an exercise price of $92.92 that vests pro rata over five years from the grant date and expires 10/26/2033. All reported holdings are direct.
Transcat Inc (TRNS) director Oksana S. Dominach reported equity transactions on Form 4 reflecting restricted stock unit (RSU) activity and an outstanding stock option. On 09/11/2025, 704 RSUs were reported as acquired under transaction code M and converted into common stock at no cash price; 1,587 RSUs were reported as acquired on 09/10/2025 but vest on 09/10/2026 per the award terms. The filing also shows a fully vested stock option to purchase 10,000 shares at $26.27 expiring 10/22/2029. Following the reported transactions, Dominach beneficially owns 4,346 shares.
Craig D. Cairns, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership. The filing shows restricted stock units (RSUs) converting to common stock on a one-for-one basis, with 1,587 RSUs reported as acquired on 09/10/2025 and shown as 1,587 shares beneficially owned directly. An additional 704 RSUs are reported with transaction code M on 09/11/2025. Following the reported transactions, Mr. Cairns directly beneficially owns 5,003 shares of common stock and holds a stock option for 10,000 shares with a $47.14 exercise price exercisable pro rata through 05/12/2031. He also has indirect holdings via the Howe & Rusling 401(k) plan (430 shares) and Roth 401(k) plan (1,910 shares). The filing was signed by an attorney-in-fact on Mr. Cairns' behalf.